NCT02482454 Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT02479178 A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck Status TERMINATED Phase PHASE2
NCT02456714 Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma Status COMPLETED Phase PHASE2
NCT02452970 RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy Status TERMINATED Phase PHASE2
NCT02428855 Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma Status COMPLETED Phase PHASE2
NCT02393248 Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) Status TERMINATED Phase PHASE1/PHASE2
NCT02379377 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02375880 Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder Status COMPLETED Phase PHASE1
NCT02374489 A Phase II Trial of LDK378 in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar Cholangiocarcinoma Status TERMINATED Phase PHASE2
NCT02351765 ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers Status COMPLETED Phase PHASE1
NCT02232932 Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma Status UNKNOWN Phase NA
NCT02232633 A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer Status COMPLETED Phase PHASE2
NCT02181634 Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma Status COMPLETED Phase PHASE2
NCT02174575 Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery Status WITHDRAWN Phase PHASE4
NCT02170090 Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02128282 Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT02106871 Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer Status WITHDRAWN Phase PHASE1